Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| HZNP | Horizon Therapeutics Plc | 24.45% | 76.90 | 6.5% | $150.39m | |
| VRX | Valeant Pharmaceuticals International, Inc. | 1.84% | 19.34 | 14.1% | $113.80m | |
| CTLT | Catalent, Inc. | 1.60% | 89.59 | 2.1% | $94.48m | |
| JAZZ | Jazz Pharmaceuticals Plc | 10.99% | 122.62 | 2.4% | $64.98m | |
| BHC | Bausch Health Cos., Inc. | 1.84% | 19.34 | 0.0% | $64.75m | |
| TNXP | Tonix Pharmaceuticals Holding Corp. | 5.79% | 1.28 | 3.9% | $63.68m | |
| ARGX | argenx SE | 0.33% | 232.38 | 0.0% | $46.77m | |
| PCRX | Pacira Biosciences, Inc. | 2.24% | 56.52 | 10.3% | $44.88m | |
| ICLR | ICON plc | 1.58% | 190.03 | 4.3% | $42.49m | |
| UTHR | United Therapeutics Corp. | -0.73% | 113.26 | 14.1% | $42.17m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 0.72% | 47.92 | 16.8% | $41.75m | |
| PRGO | Perrigo Co. Plc | -5.06% | 52.33 | 6.8% | $40.16m | |
| GWPH | GW Pharmaceuticals Plc | -0.41% | 134.81 | 6.2% | $38.00m | |
| MYOK | MyoKardia, Inc. | 2.49% | 100.44 | 1.8% | $36.95m | |
| AMRN | Amarin Corp. Plc | -3.27% | 6.80 | 1.5% | $36.10m |
Company Profile
Verona Pharma Plc operates as a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. Its lead product candidate, ensifentrine, has the potential to be the first therapy for the treatment of respiratory diseases that combines bronchodilator and anti-inflammatory activities in one compound. The company was founded by Michael J. A. Walker and Clive P. Page on February 24, 2005 and is headquartered in London, the United Kingdom.